Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-03-24

Clinical Trial Update: Transcranial Magnetic Stimulation (TMS) for Negative Symptoms in Schizophrenia Spectrum Disorders [NA]

View source ↗

Summary

This clinical trial update indicates that a study evaluating transcranial magnetic stimulation for negative symptoms in schizophrenia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcranial Magnetic Stimulation (TMS)

Snippet

Sponsor: The University of Texas Health Science Center, Houston | Conditions: Schizophrenia Spectrum Disorder | NA | Status: RECRUITING